PHLDB3 Activators
PHLDB3 Activators are a diverse set of chemical compounds that indirectly enhance the functional activity of PHLDB3 through various signaling pathways, each influencing cellular processes that PHLDB3 is directly involved in. For example, Forskolin and Dibutyryl-cAMP both increase intracellular cAMP levels, leading to the activation of PKA; this, in turn, phosphorylates substrates that can enhance the activity of PHLDB3 in cytoskeletal organization and cell signaling. Ionomycin, by increasing intracellular calcium, activates calcium-dependent kinases that might phosphorylate PHLDB3 or its associated proteins, thereby potentiating PHLDB3's role in cell adhesion. PMA, as an activator of PKC, and Bisindolylmaleimide I, despite being a PKC inhibitor, each contribute to the modulation of kinase activity, resulting in the phosphorylation of proteins that interact with PHLDB3, thus enhancing its regulatory role in cell motility and polarity.
Additionally, compounds such as Calyculin A and Okadaic acid, through the inhibition of PI3K and protein phosphatases, respectively, create a cellular environment with altered phosphorylation dynamics, which could lead to the compensatory activation of pathways involving PHLDB3, increasing its functional activity. Sphingosine-1-phosphate, through its receptor-mediated signaling, can cause cytoskeletal rearrangements that enhance PHLDB3's activity in cell signaling. Anisomycin, a JNK activator, can influence the MAPK signaling cascade, potentially upregulating genes that synergize with PHLDB3 or shifting signaling balances, thereby augmenting PHLDB3's role in cell migration and adhesion. EGCG, with its inhibitory action on multiple kinases, has the potential to fine-tune the signaling pathways that PHLDB3 is a part of, thus enhancing its role in cellular processes such as migration and adhesion, highlighting the intricate network of signaling that converges on the activation of PHLDB3.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to increased levels of cyclic AMP (cAMP) in cells. Elevated cAMP activates protein kinase A (PKA), which could phosphorylate downstream targets that enhance the activity of PHLDB3 in its role in cytoskeletal organization. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. This calcium influx can activate calcium-dependent protein kinases, which may then phosphorylate PHLDB3 or associated proteins, resulting in enhanced PHLDB3 activity in cell adhesion and signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which can lead to the phosphorylation of proteins that interact with PHLDB3, thereby enhancing its role in regulating cell motility and polarity. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels of cellular proteins. This can promote the activation of signaling pathways that include PHLDB3, thus enhancing its function. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is another phosphatase inhibitor that prevents dephosphorylation of proteins, which could lead to an increase in PHLDB3 activity due to elevated phosphorylation in the signaling pathways it is involved in. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a selective PKC inhibitor that can lead to altered signaling dynamics, potentially enhancing PHLDB3's involvement in cellular processes such as migration and adhesion by modifying kinase activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate interacts with its G-protein-coupled receptors, which can lead to actin cytoskeletal rearrangements where PHLDB3 may be functionally enhanced as part of the signaling cascade. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator that can lead to the phosphorylation of c-Jun, which may upregulate genes that synergize with PHLDB3, thereby enhancing its functional activity in cellular stress responses. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor that has a broad range of targets, potentially leading to the enhancement of PHLDB3 activity by affecting signaling pathways that regulate cell adhesion and migration. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cAMP analog that activates PKA, leading to phosphorylation events that can enhance the activity of PHLDB3 in cellular signaling pathways related to cytoskeletal dynamics. | ||||||